Chicago, Aug. 05, 2024 (GLOBE NEWSWIRE) -- The "Microfluidics Market Size, Share & Trends by Product (Device, Component (Chip, Sensor, Microneedle, Pump, Valve), Application (IVD (POC, Clinical, Vet), Research (Proteomic, Genomic, Cell-based, Capillary), Manufacturing), End User (Pharma, Hospital) - Global Forecast to 2028”, report highlights substantial growth projections. It anticipates the market to escalate from $22.3 billion in 2023 to $41.1 billion by 2028, at a notable CAGR of 13.0%. The microfluidics market is experiencing growth due to advancements in technology that enhance testing speed, accuracy, and cost-efficiency while minimizing reagent use. The rising demand for point-of-care test kits and the development of new drug delivery systems, such as portable and wearable devices, are further driving market expansion. Technological progress, such as the integration of microfluidics in lab-on-a-chip applications, is making significant strides in the healthcare sector, improving drug development and clinical studies. However, challenges like the slow incorporation of microfluidics into existing workflows and the need for standardization and commercialization pose obstacles. The market is dominated by companies like Thermo Fisher Scientific, PerkinElmer, and Illumina, with North America leading in market share due to supportive government initiatives and increased healthcare spending.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1305

Danaher Corporation: Market Leader with Extensive Microfluidics Expertise

Danaher Corporation leads the microfluidics market due to its extensive experience and broad product portfolio, which includes bioanalyzers, genomic equipment, chromatographic systems, and immunoassay testing tools. With over 30 years of innovation in microfluidics-based devices, Danaher is recognized for the precision and high quality of its equipment. The company invests 5% to 6% of its total revenue into R&D to continually enhance its offerings. Danaher's Life Sciences and Diagnostics segments, which include brands like Leica Microsystems and Pall Corporation, are instrumental in driving its market leadership.

Illumina: Innovator in Genomic Sequencing and Microfluidics

Illumina holds the second position in the microfluidics market, attributed to its advanced genomic sequencing products such as HiSeq, MiSeq, and NovaSeq. The company's significant investment in R&D—approximately 20% of its revenue—supports the development of cutting-edge microfluidic products for genomic and cell line research. Illumina's VeraCode platform, a microfluidic device used for cancer cell detection, further enhances its position in the diagnostics sector.

Thermo Fisher Scientific: Leading with Comprehensive Microfluidics Solutions

Thermo Fisher Scientific ranks third in the microfluidics market, owing to its extensive range of microfluidic products and services. The company's robust portfolios in clinical chemistry, drug monitoring, and molecular diagnostics, combined with its global distribution network, bolster its market presence. Thermo Fisher's strategic mergers and acquisitions, along with the introduction of the TagCheck COVID-19 PCR test kit, have solidified its market position. The company invested around $1 billion in R&D in 2022, driving innovation in gene sequencing, spectrometry, and clinical diagnostics through advanced microfluidic technologies.

Request for FREE Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=1305

Microfluidics Market Segmentation

The microfluidics market is divided into two main product categories: microfluidic-based devices and microfluidic components. In 2022, the microfluidic-based devices segment is expected to experience the highest growth rate. This growth is driven by the increasing adoption of these devices in life science research, enhanced drug analysis and development, and advancements in point-of-care technology. Innovations such as 3D printing and laser micromachining have also contributed to the expansion of microfluidic devices, which offer advantages like automated operations, scalability, high throughput, small size, and low reagent consumption, resulting in substantial market growth potential.

Application-Based Market Insights

The market is segmented by application into In-Vitro Diagnostics (IVD), Pharmaceutical & Life Science Research and Manufacturing, and Therapeutics. The IVD segment holds the largest market share and includes clinical diagnostics, point-of-care, and veterinary diagnostics. The increasing incidence of diseases like Ebola, SARS, H1N1, and MERS-CoV, coupled with rising demand for point-of-care testing kits, is boosting this segment. Innovations in clinical diagnostics, driven by system engineering, automation, and IT convergence, are enhancing disease understanding and driving market growth.

Regional Market Overview

Geographically, the microfluidics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America led the market in 2022, supported by high-quality resources for biotechnological research and clinical studies and a significant presence of microfluidic device manufacturers. However, the Asia Pacific (APAC) region is experiencing notable growth due to increased R&D activities, government support for drug discovery, local manufacturing of microfluidic components, and expanding pharmaceutical industries.

For More information, Inquire Now.

Related Reports:

Lateral Flow Assays Market
Immunoassay Market
In Vitro Diagnostics Market
Mass Spectrometry Market
Point of Care Diagnostics Market

Get access to the latest updates on Microfluidics Companies and Microfluidics Market Share

About MarketsandMarkets™

MarketsandMarkets™ has been recognized as one of America’s best management consulting firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients.

Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes.

The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.